Abstract

Meninges cover the surface of the brain and spinal cord and contribute to protection and immune surveillance of the central nervous system (CNS). How the meningeal layers establish CNS compartments with different accessibility to immune cells and immune mediators is, however, not well understood. Here, using 2-photon imaging in female transgenic reporter mice, we describe VE-cadherin at intercellular junctions of arachnoid and pia mater cells that form the leptomeninges and border the subarachnoid space (SAS) filled with cerebrospinal fluid (CSF). VE-cadherin expression also marked a layer of Prox1+ cells located within the arachnoid beneath and separate from E-cadherin+ arachnoid barrier cells. In vivo imaging of the spinal cord and brain in female VE-cadherin-GFP reporter mice allowed for direct observation of accessibility of CSF derived tracers and T cells into the SAS bordered by the arachnoid and pia mater during health and neuroinflammation, and detection of volume changes of the SAS during CNS pathology. Together, the findings identified VE-cadherin as an informative landmark for in vivo imaging of the leptomeninges that can be used to visualize the borders of the SAS and thus potential barrier properties of the leptomeninges in controlling access of immune mediators and immune cells into the CNS during health and neuroinflammation.

How the leptomeninges establish CNS compartments with different accessibility to immune cells and immune mediators remains unknown. Here, the authors show junctional localization of VE-cadherin in arachnoid and pia mater cells, which allows to visualize potential barrier properties of the leptomeninges in vivo.

Details

Title
VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation
Author
Mapunda, Josephine A. 1   VIAFID ORCID Logo  ; Pareja, Javier 1   VIAFID ORCID Logo  ; Vladymyrov, Mykhailo 1   VIAFID ORCID Logo  ; Bouillet, Elisa 1   VIAFID ORCID Logo  ; Hélie, Pauline 1   VIAFID ORCID Logo  ; Pleskač, Petr 1 ; Barcos, Sara 1 ; Andrae, Johanna 2   VIAFID ORCID Logo  ; Vestweber, Dietmar 3   VIAFID ORCID Logo  ; McDonald, Donald M. 4   VIAFID ORCID Logo  ; Betsholtz, Christer 5 ; Deutsch, Urban 1 ; Proulx, Steven T. 1 ; Engelhardt, Britta 1   VIAFID ORCID Logo 

 University of Bern, Theodor Kocher Institute, Bern, Switzerland (GRID:grid.5734.5) (ISNI:0000 0001 0726 5157) 
 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
 Max-Planck- Institute for Molecular Biomedicine, Münster, Germany (GRID:grid.461801.a) (ISNI:0000 0004 0491 9305) 
 University of California San Francisco, Cardiovascular Research Institute, UCSF Helen Diller Family Comprehensive Cancer Center, and Department of Anatomy, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811) 
 Uppsala University, Department of Immunology, Genetics and Pathology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457); Karolinska Institute, Department of Medicine-Huddinge, Huddinge, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
Pages
5837
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2866604044
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.